Sera Prognostics (SERA) Enterprise Value Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.61% |
| Dec 31, 2025 | 15.22% |
| Sep 30, 2025 | 12.96% |
| Jun 30, 2025 | 21.16% |
| Mar 31, 2025 | 12.79% |
| Dec 31, 2024 | 5.79% |
| Sep 30, 2024 | -7.88% |
| Jun 30, 2024 | 20.18% |
| Mar 31, 2024 | 25.17% |
| Dec 31, 2023 | 40.66% |
| Sep 30, 2023 | 48.05% |
| Jun 30, 2023 | 40.31% |
| Mar 31, 2023 | 34.19% |
| Dec 31, 2022 | 21.32% |
| Sep 30, 2022 | 26.02% |
| Jun 30, 2022 | -17.61% |
| Dec 31, 2021 | -676.73% |